Speaker
Description
TRIUMF has a long history of medical isotope production. For more than 40 years, the Life Sciences Division at TRIUMF has produced isotopes for Positron Emission Tomography (PET) for the local hospitals. Recently, the division has taken on the challenge to expand the facility's isotope repertoire to therapeutic from diagnostic isotopes, allowing thera-nostic isotope combinations. We utilize TRIUMF's cyclotrons spanning in energy from 13 MeV to 520 MeV to develop new production methods for alpha emitters (e.g. Ac-225 and At-211), which have garnered great interest in the medical community for their potent efficacy in cancer treatments. We are also making progress in developing and testing Auger emitters (e.g. Hg-197, Sb-119), which show great promise.
